Bicycle Therapeutics BCYC
NASDAQ BCYC
$4.26 +0.03 (+0.59%)
As of: Sep 4, 2026 · 3:13 PM EDT

Bicycle Therapeutics (BCYC) Tax Provisions (2018 - 2026)

Bicycle Therapeutics' (BCYC) quarterly Tax Provisions came in at $100000.0 in Q2 2026, up 143.29% YoY from $41103.2 in Q2 2025, and down 50.0% on a QoQ basis from $200000.0 in Q1 2026.

Analysis

Bicycle Therapeutics (BCYC) Tax Provisions (2018 - 2026) Analysis & Trends

Bicycle Therapeutics (BCYC) has 9 years of Tax Provisions data on file, last reported at $100000.0 in Q2 2026.

  • Quarterly Tax Provisions rose 143.29% year-over-year to $100000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$53.1 million (down 802.94% YoY) and the FY2025 annual result came in at -$54.7 million, down 1039.62% from the prior year.
  • Tax Provisions slipped to $100000.0 in Q2 2026, from $200000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $4.6 million in Q4 2022 to a low of -$53.6 million in Q4 2025.
  • A 5-year average of -$3.2 million and a median of -$409500.0 in 2022 frame the typical range for Tax Provisions.
  • Annual changes were most pronounced in 2023 — Tax Provisions jumped 1066.39% — and 2025, when it sank 4771.73%.
  • Tracing BCYC's Tax Provisions over 5 years: stood at $4.6 million in 2022, then slumped by 165.54% to -$3.0 million in 2023, then surged by 63.16% to -$1.1 million in 2024, then slumped by 4771.73% to -$53.6 million in 2025, then jumped by 100.19% to $100000.0 in 2026.
  • The last three Tax Provisions figures came in at $100000.0 (Q2 2026), $200000.0 (Q1 2026), and -$53.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 292.00 Mn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 230.90 Mn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -59.00 Mn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 15.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 75.45 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 13.31 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.90 Mn
10 Bicycle Therapeutics 297.72 Mn 297.72 Mn - 100,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100,000.00
Mar 31, 2026 200,000.00
Dec 31, 2025 -53.59 Mn
Sep 30, 2025 205,000.00
Jun 30, 2025 -231,000.00
Mar 31, 2025 -1.10 Mn
Dec 31, 2024 -1.10 Mn
Sep 30, 2024 -3.45 Mn
Jun 30, 2024 115,000.00
Mar 31, 2024 -400,000.00
Dec 31, 2023 -2.99 Mn
Sep 30, 2023 2.30 Mn
Jun 30, 2023 -517,000.00
Mar 31, 2023 -618,000.00
Dec 31, 2022 4.56 Mn
Sep 30, 2022 -238,000.00
Jun 30, 2022 -447,000.00
Mar 31, 2022 -419,000.00
Dec 31, 2021 -785,000.00
Sep 30, 2021 -415,000.00